Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

STEMLINE THERAPEUTICS INC (STML)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsMar-31-20Dec-31-19Sep-30-19Jun-30-19Mar-31-19Dec-31-18Sep-30-18Jun-30-18
   10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q
Net income  -21.3-17.7-14.9-16.8-27.4-26.6-21.0-18.9
Depreciation and amortization   [+]0.00.00.00.00.00.00.00.0
Stock-based compensation  4.55.25.48.37.25.33.13.4
Change in working capital   [+]3.11.6-3.5-12.4-2.52.9-0.7-2.5
Other operating activities  0.0-0.4-0.3-0.30.50.00.00.0
Cash from operations  -13.8-11.2-13.2-21.2-22.1-18.4-18.7-18.0
   
Capital expenditures  0.00.10.00.0-0.10.1-0.10.0
Purchases of short-term investments, net  29.3179.6-60.113.8-49.657.813.410.8
Other cash from investing   -183.0   -41.6  
Cash from investing  29.3-3.3-60.113.8-49.616.313.310.8
   
Issuance of common stock, net    82.2 86.2-0.10.08.3
Option exercises  0.00.61.20.30.0 0.10.4
Other cash from financing  0.21.32.70.60.10.00.11.0
Cash from financing  0.20.783.60.386.30.00.18.8
   
Free cash flow  -13.8-11.1-13.2-21.2-22.2-18.3-18.8-18.0
        Per share (diluted)  ($0.29)($0.26)($0.30)($0.53)($0.59)($0.65)($0.65)($0.63)

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy